Business Description
Genomic Valley Biotech Ltd
ISIN : INE574D01010
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.53 | |||||
Interest Coverage | 5071.5 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.04 | |||||
Beneish M-Score | 56.29 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 47.3 | |||||
3-Year EBITDA Growth Rate | 4.7 | |||||
3-Year EPS without NRI Growth Rate | 47 | |||||
3-Year FCF Growth Rate | -169.5 | |||||
3-Year Book Growth Rate | -11.3 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 16.59 | |||||
9-Day RSI | 27.07 | |||||
14-Day RSI | 33.15 | |||||
6-1 Month Momentum % | 46.84 | |||||
12-1 Month Momentum % | 60 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.69 | |||||
Quick Ratio | 1.69 | |||||
Cash Ratio | 0.01 | |||||
Days Sales Outstanding | 472.5 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | 87.35 | |||||
Net Margin % | 90.67 | |||||
FCF Margin % | -67.06 | |||||
ROE % | 30.07 | |||||
ROA % | 20.64 | |||||
ROIC % | 22.02 | |||||
ROC (Joel Greenblatt) % | 39.57 | |||||
ROCE % | 28.45 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 9.42 | |||||
PE Ratio without NRI | 9.68 | |||||
PS Ratio | 8.55 | |||||
PB Ratio | 2.77 | |||||
Price-to-Tangible-Book | 2.49 | |||||
EV-to-EBIT | 8.41 | |||||
EV-to-EBITDA | 8.4 | |||||
EV-to-Revenue | 7.62 | |||||
EV-to-FCF | -13.51 | |||||
Price-to-Graham-Number | 0.97 | |||||
Price-to-Net-Current-Asset-Value | 4.02 | |||||
Earnings Yield (Greenblatt) % | 11.9 | |||||
FCF Yield % | -8.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Genomic Valley Biotech Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 11.612 | ||
EPS (TTM) (₹) | 3.45 | ||
Beta | 0.52 | ||
Volatility % | 48.57 | ||
14-Day RSI | 33.15 | ||
14-Day ATR (₹) | 2.071479 | ||
20-Day SMA (₹) | 34.3835 | ||
12-1 Month Momentum % | 60 | ||
52-Week Range (₹) | 20.65 - 50.14 | ||
Shares Outstanding (Mil) | 3.05 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Genomic Valley Biotech Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Genomic Valley Biotech Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Genomic Valley Biotech Ltd Frequently Asked Questions
What is Genomic Valley Biotech Ltd(BOM:539206)'s stock price today?
When is next earnings date of Genomic Valley Biotech Ltd(BOM:539206)?
Does Genomic Valley Biotech Ltd(BOM:539206) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |